DarioHealth’s cardiometabolic suite selected by two employers

DarioHealth announced two new contracts to provide integrated chronic condition management solutions for two employers beginning in Q2. The employers, a national supply chain company and a regional education organization, selected Dario’s cardiometabolic suite to help improve outcomes for employees with cardiometabolic health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including support for individuals taking a GLP-1 medication. Employees enrolled in Dario’s cardiometabolic solution who are taking a GLP-1 medication will also have access to a tailored experience to support long-term behavior change.